An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's disease.
about
Sirtuin functions and modulation: from chemistry to the clinicDual and Opposing Roles of MicroRNA-124 in Epilepsy Are Mediated through Inflammatory and NRSF-Dependent Gene Networks.Histone Deacetylase (HDAC) Inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regenerationSIRT1 Activity Is Linked to Its Brain Region-Specific Phosphorylation and Is Impaired in Huntington's Disease Mice.Sirtuin 1 stimulates the proliferation and the expression of glycolysis genes in pancreatic neoplastic lesions.Seeding for sirtuins: microseed matrix seeding to obtain crystals of human Sirt3 and Sirt2 suitable for soaking.Investigational agents for the management of Huntington's disease.The Current State of NAD(+) -Dependent Histone Deacetylases (Sirtuins) as Novel Therapeutic Targets.Sirtuins Expression and Their Role in Retinal Diseases.Huntington's Disease-Update on Treatments.Transcriptional Dysregulation and Post-translational Modifications in Polyglutamine Diseases: From Pathogenesis to Potential Therapeutic Strategies.Rating Scales and Performance-based Measures for Assessment of Functional Ability in Huntington's Disease: Critique and RecommendationsMolecular Imaging of Sirtuin1 Expression-Activity in Rat Brain Using Positron-Emission Tomography-Magnetic-Resonance Imaging with [F]-2-Fluorobenzoylaminohexanoicanilide
P2860
Q26745884-ABFCBD0D-B03F-4889-9CD8-87B4FA49A1F7Q27319868-59CE8652-E936-410E-9D55-6ED89B46B0B1Q28080593-AD35FC3A-F5AA-4DDF-A45A-FD35B67D9190Q35905545-97F5947E-5DD3-4944-AA9F-9DE02A960BD9Q38753641-61D34583-9BAE-4C59-BD6F-69C82B8FFE76Q38936741-236A2CBB-53A1-48F9-A750-A85BE70E8214Q39031769-16B141EA-79E5-4137-96C1-13B9C5265C14Q39091771-CB0AA2D9-38D6-46E4-B243-8DA18C3E66EFQ39135669-B920ED10-34C2-48E9-857B-9FC159B42DA6Q39190617-7C10A1E8-8472-43F7-9C9A-51254A218E57Q54965657-1E2CB0CD-43FB-4137-BBD8-5F903D285BF4Q58574520-6FE73336-DD12-498C-A34D-DFC0D62EFE60Q58784374-BBF95436-62EF-45B4-84FA-823BF7E58500
P2860
An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's disease.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
An exploratory double-blind, r ...... nts with Huntington's disease.
@ast
An exploratory double-blind, r ...... nts with Huntington's disease.
@en
type
label
An exploratory double-blind, r ...... nts with Huntington's disease.
@ast
An exploratory double-blind, r ...... nts with Huntington's disease.
@en
prefLabel
An exploratory double-blind, r ...... nts with Huntington's disease.
@ast
An exploratory double-blind, r ...... nts with Huntington's disease.
@en
P2093
P2860
P50
P356
P1476
An exploratory double-blind, r ...... nts with Huntington's disease.
@en
P2093
Anna Baran
Borje Darpo
Claudia Lamanna
Claus A Andersen
Daniela Diamanti
Danuta Ryglewicz
Elisa Mori
Enrica Diodato
G Bernhard Landwehrmeyer
Giovanna Tripepi
P2860
P304
P356
10.1111/BCP.12512
P407
P577
2015-03-01T00:00:00Z